AMZN vs OBIO · P/E 31, rev $716.92B vs rev $198.0K
Amazon.com Inc (AMZN) versus Orchestra BioMed Holdings Inc. (OBIO) — a side-by-side from cached financials, not a winner call.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
AMZN currently screens at market cap $2.55T and trailing P/E 30.6. OBIO currently screens at market cap $231.7M.
Not investment advice. Open the AMZN and OBIO stock pages for the full models.
Not investment advice.